Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Rhea-AI Summary

Aethlon Medical (Nasdaq: AEMD) will release its fiscal year-end financial results on June 27, 2024, at 4:15 p.m. ET. The company focuses on developing therapeutic products for cancer and serious infectious diseases.

Management will host a conference call the same day at 4:30 p.m. ET to discuss the financial results and recent corporate developments. The call will include a Q&A session.

Participants can register for the call at https://dpregister.com/sreg/10190237/fce977aef1, where they will receive dial-in numbers. Those without internet access can dial in toll-free at 1-844-836-8741 or internationally at 1-412-317-5442.

A replay of the call will be available until July 27, 2024, via Aethlon Medical's website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international), using replay conference ID 6876352.

Positive

• Scheduled financial results release provides transparency and timely information.
• Conference call allows direct interaction with management, offering insights into financial results and corporate developments.

Negative

• None.

SAN DIEGO, June 21, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal year ended March 31, 2024, at 4:15 p.m. ET on Thursday, June 27, 2024.

Management will host a conference call on Thursday, June 27, 2024, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session.

Interested parties can register for the conference by navigating to https://dpregister.com/sreg/10190237/fce977aef1. Please note that registered participants will receive their dial-in number upon registration.

Interested parties without internet access or unable to pre-register may dial in by calling:

PARTICIPANT DIAL IN (TOLL FREE): 1-844-836-8741
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442

All callers should ask for the Aethlon Medical, Inc. conference call.

A replay of the call will be available approximately one hour after the end of the call through July 27, 2024. The replay can be accessed via Aethlon Medical's website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada toll free at 1-855-669-9658. The replay conference ID number is 6876352.

About Aethlon and the Hemopurifier^®
Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and in pre-clinical studies, the Hemopurifier has demonstrated the removal of harmful exosomes from biological fluids, utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Additional information can be found at www.AethlonMedical.com.

Company Contact:
Jim Frakes
Interim Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com

View original content:https://www.prnewswire.com/news-releases/aethlon-medical-to-release-fiscal-year-end-financial-results-and-host-conference-call-on-june-27-2024-302178802.html

SOURCE Aethlon Medical, Inc.

FAQ

When will Aethlon Medical release its fiscal year-end financial results?

Aethlon Medical will release its fiscal year-end financial results on June 27, 2024, at 4:15 p.m. ET.

What time is the Aethlon Medical conference call regarding the fiscal year-end financial results?

The Aethlon Medical conference call is scheduled for 4:30 p.m. ET on June 27, 2024.

How can I register for the Aethlon Medical conference call?

You can register for the Aethlon Medical conference call by visiting https://dpregister.com/sreg/10190237/fce977aef1.

What if I can't access the internet to register for the Aethlon Medical conference call?

You can dial in toll-free at 1-844-836-8741 or internationally at 1-412-317-5442 to join the Aethlon Medical conference call.

Will there be a replay available for the Aethlon Medical conference call?

Yes, a replay will be available via Aethlon Medical's website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) until July 27, 2024.